ProFund Advisors »

Celldex Therapeutics shares owned by ProFund Advisors

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by ProFund Advisors from 13F filings

Historical chart of ProFund Advisors investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by ProFund Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by ProFund Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.3M 30k 41.97
2023-09-30 $772k 28k 27.52
2023-06-30 $1.3M 37k 33.93
2023-03-31 $985k 27k 35.98